Actavis, Mylan appeal certification orders in US pharma antitrust litigation
MLex Summary: Actavis and Mylan asked the US Court of Appeals for the Third Circuit to reverse the grant of class certification for direct purchasers and end-payers of generical pharmaceuticals. They...To view the full article, register now.
Already a subscriber? Click here to view full article